14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SYGGF
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Synairgen plc Stock and on which exchange is it traded?
The symbol for Synairgen plc is SYGGF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Synairgen plc Stock?
Synairgen plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Synairgen plc Stock?
Synairgen plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Synairgen plc Stock.

What's the current price of Synairgen plc Stock?
As of the end of day on the Jun 17, 2024, the price of an Synairgen plc (SYGGF) share was $0.0830.

What is the 52-week high and low for Synairgen plc Stock?
The 52-week high for Synairgen plc Stock is $0.145 and the 52-week low is $0.0450.

What is the market capitalization of Synairgen plc Stock?
As of the Jun 17, 2024, the market capitalization of Synairgen plc is 15.119M.

When is the next earnings date for Synairgen plc?
The upcoming earnings date for Synairgen plc is Sep 19, 2024.
Click to get the best stock tips daily for free!

About Synairgen plc

Synairgen plc Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic ... SYGGF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT